Fatty Acid Synthase (FAS) is a marker of increased risk of recurrence in lung carcinoma

Anticancer Research

Volumn 24, Issue 6, 2004, Pages 4169-4173

  Visca, Paolo ^b   Sebastiani, Valeria ^a   Botti, Claudio ^b   Diodoro, Maria Grazia ^b   Lasagni, Roberto Pasquali ^b   Romagnoli, Francesca ^b   Brenna, Alessia ^b   De Joannon, Barbara Capezzone ^a   Donnorso, Raffaele Perrone ^b   Lombardi, Giuseppe ^a   Alo, Piero Luigi ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Carcinoma; Fatty acid synthase; Lung; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG LOBECTOMY; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; CANCER STAGING; ENZYMOLOGY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR; TUMOR RECURRENCE;

FATTY ACID SYNTHASE;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FATTY ACID SYNTHETASE COMPLEX; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RISK FACTORS;

EID: 20144389083     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Kukunoor R, Shah J and Mekhail T: Target therapy for lung cancer. Curr Oncol Rep 5(4): 326-333, 2003.
2. Kuo CW, Chen YM, Chao JY, Tsai CM and Perng RP: Non-small lung cancer in very young and very old patients. Chest 117(2): 354-357, 2000.
3. Wakil S: Fatty acid synthase: a proficient multifunctional enzyme. Biochemistry 28: 4523-4530, 1989.
4. Latasa MJ, Moon YS, Kim KH and Sul HS: Nutritional regulation of the fatty acid synthase promoter in vivo: sterol regulatory element binding protein functions through an upstream region containing a sterol regulatory element. Proc Natl Acad Sci USA 97(19): 10619-10624, 2000.
5. Wilentz RE, Witters LA and Pizer ES: Lipogenic enzymes fatty acid synthase and acetyl-CoA carboxylase are co-expressed with sterol regulatory element binding protein and Ki-67 in fetal tissues. Pediatr Dev Pathol 3(6): 525-531, 2000.
6. Alo PL, Visca P, Marci A, Botti C, Mangoni A and Di Tondo U: Expression of fatty acid synthase as a predictor of recurrence in Stage I breast carcinoma patients. Cancer 77: 474-482, 1996.
7. Epstein JI, Carmichael M and Partin AW: OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate. Urology 45: 81-86, 1995.
8. Nemoto T, Terashima S, Kogure M, Hoshino Y, Kusakabe T, Suzuki T and Gotoh M: Overexpression of fatty acid synthase in oesophageal squamous cell dysplasia and carcinoma. Pathobiology 69(6): 297-303, 2001.
9. World Health Organization: Histological typing of lung tumors. In: World Health Organization (second edition), Geneva, 1981.
10. Muller KM: Histological classification and histogenesis of lung cancer. Eur J Resp Dis 65(1): 4-19, 1984.
11. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin LH and Yarbro JW, editors. AJCC Cancer Staging Handbook, fifth edition. Philadelphia-New York: Lippincott-Raven publishers, 1998, pp 117-127.
12. Weiss L, Hoffman GE, Schreiber R, Andres H, Fuchs E, Korber E and Kolb HJ: Fatty acid biosynthesis in man: a pathway of minor importance. Purification, optimal assay conditions and organ distribution of fatty-acid synthase. Biol Chem Hoppe-Seyler 567: 905-12, 1986.
13. Bresler R and Wakil SJ: Studies on the mechanism of fatty acid synthesis: the conversion of malonyl-CcA to long chain fatty acid. J Biol Chem 256: 1643-1651, 1961.
14. Alo PL, Visca P, Mazzaferro S, Eleuteri Serpieri D, Mangoni A, Botti C, Monaco S, Carboni M, Zaraca F, Trombetta G and Di Tondo U: Immunohistochemical study of fatty acid synthase, Ki67, proliferating cell nuclear antigen and p53 expression in hyperplastic parathyroids. Ann Diagn Pathol 3(5): 287-293, 1999.
15. Chalbos D, Escot C, Joyeux C, Tissot-Carayon MJ, Pages A and Rochefort H: Expression of the progestin-induced fatty acid synthetase in benign mastopathies and breast cancer as measured by RNA in situ hybridisation. J Natl Cancer Inst 82: 602-606, 1990.
16. Oskovian B: Overexpression of fatty acid synthase in SKBR3 breast cancer cells line mediated via a transcriptional mechanism. Cancer Lett 149: 43-51, 2000.
17. Alo PL, Visca P, Framarino ML, Botti C, Monaco S, Sebastiani V, Serpieri DE and Di Tondo U: Immunohistochemical study of fatty acid synthase in ovarian neoplasms. Oncol Rep 7: 1383-1388, 2000.
18. Swinnen JV, Vanderhoydonc F, Elgamal AA, Helen M, Vercaeren I, Joniau S, Van Poppel H, Baert L, Goossens K, Heyns W and Verhoeven G: Selective activation of the fatty acid synthetic pathway in human prostate cancer. Int J Cancer 18(2): 176-179, 2000.
19. Visca P, Sebastiani V, Pizer ES, Botti C, De Carli P, Filippi S, Monaco S and Alo PL: Immunohistochemical expression and prognostic significance of fatty acid synthase and GLUT1 in bladder carcinoma. Anticancer Res 23: 335-9, 2003.
20. Camassei FD, Cozza R, Acquaviva A, Jenkner A, Rava L, Gareri R, Donfrancesco A, Bosman C, Vadala P, Hadjistilianou T and Boldrini R: Expression of the lipogenic enzyme fatty acid synthase in retinoblastoma and its correlation with tumor aggressiveness. Invest Opthalmol Vis Sci 44(6): 2399-2403, 2003.
21. Gabrielson EW, Pinn ML, Testa JR and Kuhajda FP: Increased fatty acid synthase is a therapeutic target in mesothelioma. Clin Cancer Res 7(1): 153-157, 2001.
22. Innocenzi D, Alo PL, Balzani A, Sebastiani V, Silipo V, La Torre G, Ricciardi G, Bosman C and Calvieri S: Fatty acid synthase expression in melanoma. J Cutan Pathol 30(1): 23-28, 2003.
23. Takahiro T, Shinichi K and Toshimitsu S: Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas. Clin Cancer Res 9: 2204-2212, 2003.
24. Wang Y, Kuhajda FP, Li JN, Pizer ES, Han WF, Sokoll LJ and Chan DW: Fatty acid synthase expression in human breast cancer cell culture supernatants and in breast cancer patients. Cancer Lett 167(1): 99-104, 2001.
25. Rashid A, Pizer ES, Moga M, Milgraum LZ, Zahurak M, Pasternack GR, Kuhajda FP and Hamilton SR: Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol 150(1): 201-208, 1997.
26. Pizer ES, Lax SF, Kuhajda FP, Pasternak GR and Kurman RJ: Fatty acid synthase expression in endometrial carcinoma: correlation with cell proliferation and hormone receptors. Cancer 83(3): 528-537, 1998.
27. Piyathilake CJ, Frost AR, Manne U, Bell WC, Weiss H, Heimburger DC and Grizzle WE: The expression of fatty acid synthase is an early event in the development and progression of squamous cell carcinoma of the lung. Human Pathol 31(9): 1068-1073, 2000.
28. Wang Y, Zhang X, Tan W, Fu J and Zhang W: Significance of fatty acid synthase expression in non-small lung cancer. Zhonghua Zhong Liu Za Zhi 24(3): 271-273, 2002.
29. Kuhajda FP, Jenner K, Wood FD, Hennigar RA, Jacobs LB, Dick JD and Pasternack GR: Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci USA 91: 6379-6383, 1994.
30. Vance D, Goldberg I, Mitsuhashi O and Bloch K: Inhibition of fatty acid synthetases by the antibiotic cerulenin. Biochem Biophys Res Commun 48: 649-56, 1972.
31. Funabashi H, Kawaguchi A, Tomoda H, Omura S, Okuda S and Iwasaki S: Binding site cerulenin in fatty acid synthetase. J Biochem 105: 751-755, 1989.
32. Slade RF, Hunt DA, Pochet MM, Venema VJ and Hennigar RA: Characterizazion and inhibition of fatty acid synthase in pediatric tumor cell lines. Anticancer Res 23: 1235-1243, 2003.
33. Pizer ES, Chrest FJ, Di Giuseppe JA and Han WF: Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res 58: 4611-4615, 1988.